Clinda-Derm en es it fr

Clinda-Derm Brand names, Clinda-Derm Analogs

Clinda-Derm Brand Names Mixture

  • No information avaliable

Clinda-Derm Chemical_Formula


Clinda-Derm RX_link

Clinda-Derm fda sheet

Clinda-Derm FDA

Clinda-Derm msds (material safety sheet)

Clinda-Derm Synthesis Reference

Birkenmeyer, U.S. Pat. 3,475,407(1970)

Clinda-Derm Molecular Weight

424.984 g/mol

Clinda-Derm Melting Point

255 oC

Clinda-Derm H2O Solubility

30.6 mg/L

Clinda-Derm State


Clinda-Derm LogP


Clinda-Derm Dosage Forms

Capsules; Intramuscular solution; Intravenousparenteral solution; Topical solution; Topical lotion; Topical gel; Vaginal cream; Vaginal ovules

Clinda-Derm Indication

For the treatment of serious infections caused by susceptible anaerobic bacteria (anaerobes, streptococci, pneumococci, and staphylococci)

Clinda-Derm Pharmacology

Clindamycin is an antibiotic, similar to and a derivative of lincomycin. Clindamycin can be used in topical or systemic treatment. It is effective as an anti-anaerobic antibiotic and antiprotozoal.

Clinda-Derm Absorption

- 90% - oral

Clinda-Derm side effects and Toxicity

Orally and parenterally administered clindamycin has been associated with severe colitis (pseudomembranous colitis) which may result in patient death. Use of the topical formulation of clindamycin results in absorption of the antibiotic from the skin surface. Diarrhea, bloody diarrhea, and colitis (including pseudomembranous colitis) have been reported with the use of topical and systemic clindamycin.

Clinda-Derm Patient Information

Clinda-Derm Organisms Affected

Enteric bacteria and other eubacteria